DE3872333T2 - Doxazosin als antiatherosklerotikum. - Google Patents

Doxazosin als antiatherosklerotikum.

Info

Publication number
DE3872333T2
DE3872333T2 DE8888305069T DE3872333T DE3872333T2 DE 3872333 T2 DE3872333 T2 DE 3872333T2 DE 8888305069 T DE8888305069 T DE 8888305069T DE 3872333 T DE3872333 T DE 3872333T DE 3872333 T2 DE3872333 T2 DE 3872333T2
Authority
DE
Germany
Prior art keywords
doxazosin
retarding
atherosclerosis
reducing
antiatherosclerotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888305069T
Other languages
English (en)
Other versions
DE3872333D1 (de
Inventor
Archie Calhoun Swindell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE3872333D1 publication Critical patent/DE3872333D1/de
Application granted granted Critical
Publication of DE3872333T2 publication Critical patent/DE3872333T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE8888305069T 1987-08-26 1988-06-03 Doxazosin als antiatherosklerotikum. Expired - Lifetime DE3872333T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/089,716 US4758569A (en) 1987-08-26 1987-08-26 Doxazosin as an anti-atherosclerosis agent

Publications (2)

Publication Number Publication Date
DE3872333D1 DE3872333D1 (de) 1992-07-30
DE3872333T2 true DE3872333T2 (de) 1992-12-03

Family

ID=22219243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888305069T Expired - Lifetime DE3872333T2 (de) 1987-08-26 1988-06-03 Doxazosin als antiatherosklerotikum.

Country Status (15)

Country Link
US (1) US4758569A (de)
EP (1) EP0305028B1 (de)
JP (1) JPS6471817A (de)
KR (1) KR910002145B1 (de)
AT (1) ATE77552T1 (de)
AU (1) AU594880B2 (de)
CA (1) CA1323572C (de)
DE (1) DE3872333T2 (de)
DK (1) DK170499B1 (de)
HU (1) HU204196B (de)
IE (1) IE60005B1 (de)
IL (1) IL86735A (de)
MY (1) MY103102A (de)
NZ (1) NZ225053A (de)
ZA (1) ZA884237B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
DK0564093T3 (da) * 1992-04-01 2000-03-27 Pfizer Hydroxylerede metabolitter og derivater af doxazosin som antiatherosklerosemidler
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
IL120303A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
EP1150669A4 (de) * 1999-02-05 2005-06-22 Angiogenix Inc Formulierungen auf l-argininbasis zur krankheitsbehandlung und deren verwendungsmethoden
KR100866820B1 (ko) 2000-07-13 2008-11-04 다케다 야쿠힌 고교 가부시키가이샤 지질 풍부 플라크 퇴축제
US20040019096A1 (en) * 2001-10-23 2004-01-29 Vlassios Andronis Novel formulations of carvedilol
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100538641B1 (ko) * 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
JP2006515765A (ja) 2002-11-15 2006-06-08 エスディージーアイ・ホールディングス・インコーポレーテッド 滑膜性関節を治療するためのコラーゲンベース材料および方法
US8118779B2 (en) 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4361564A (en) * 1978-11-30 1982-11-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4582832A (en) * 1984-10-09 1986-04-15 Pfizer Inc. Trimazosin as an anti-atherosclerosis agent

Also Published As

Publication number Publication date
HU204196B (en) 1991-12-30
ATE77552T1 (de) 1992-07-15
DE3872333D1 (de) 1992-07-30
IE60005B1 (en) 1994-05-18
JPS6471817A (en) 1989-03-16
HUT51141A (en) 1990-04-28
ZA884237B (en) 1990-02-28
IL86735A0 (en) 1988-11-30
AU594880B2 (en) 1990-03-15
KR910002145B1 (ko) 1991-04-06
CA1323572C (en) 1993-10-26
EP0305028B1 (de) 1992-06-24
DK313688A (da) 1989-02-27
JPH0575729B2 (de) 1993-10-21
US4758569A (en) 1988-07-19
IE881695L (en) 1989-02-26
EP0305028A3 (en) 1990-03-14
NZ225053A (en) 1997-02-24
KR890003379A (ko) 1989-04-14
IL86735A (en) 1994-05-30
DK313688D0 (da) 1988-06-09
MY103102A (en) 1993-04-30
EP0305028A2 (de) 1989-03-01
AU1752988A (en) 1989-03-02
DK170499B1 (da) 1995-10-02

Similar Documents

Publication Publication Date Title
DE3872333D1 (de) Doxazosin als antiatherosklerotikum.
IT1218420B (it) Agenti terapeutici comprendenti 3-1 (immidazolilalchil) indoli (e loro sali di addizione)
KR890701031A (ko) 수용성 충전제(Water soluble bulking agents)
AT387265B (de) Hydrostatisch-hydrodynamisches hybridmehrgleitfl|chenradiallager
FI955941A0 (fi) Farmaseuttisesti aktiivisia CNS-yhdisteitä
IT8821110A0 (it) Procedimento per l'allontanamento ad umido dell'anidride solforosa.
DK40488A (da) Kaliumclavulanat
IT1115153B (it) Analoghi di cefalosporina e procedimento per la loro preparazione
FR2618911B1 (fr) Flute marine d'inspection sismique
DK323589A (da) Som ildretarderende midler for visse harpikser tjenende tetrahalogenphthalatestere
IT1192795B (it) Analoghi di cefalosporina e procedimento per la loro preparazione
MX9301824A (es) Metabolitos hidroxilados y derivados de boxazosin como agentes anti-ateroscleroticos.
IT8222566A0 (it) Derivato dell'acido ursolico farmacologicamente attivo.
FR2569569B1 (fr) Exerciseur destine notamment au travail du grand ecart.
DE3767134D1 (de) Reduktion der speichereffekte eines optischen empfaengers.
IT1196212B (it) Pezzo protetto dall'usura
GR900100109A (el) Διουρητικοι παραγοντες κυκλοαλκυλο-υποκατεστημενης γλουταραμιδης.
FI881957A (fi) Foerfarande och anordning vid en isbrytare.
IT8424032A0 (it) Struttura di tampone perl'isolamento di binari.
IT8468036A0 (it) Ruote orientabili
DE3786667D1 (de) Eine elastische schicht bildender staublinderer.
IT1177474B (it) Procedimento per la preparazione di polistirene antifurto dotato di buon comportamento verso gli agenti corrosivi
FR2608005B3 (fr) Coutre, equipant notamment des semoirs en ligne
SE8800412D0 (sv) Sellskapsspelet "den resande handelsmannen"
IT8320535V0 (it) Mezzi per l'esecuzione di un gioco di societa'.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition